In Israel created gene therapy for treatment of a congenital immunodeficiency

The illness known as a syndrome of the boy in a bubble, treat by means of transplantation of stem cells of marrow, and the Israeli scientists increased efficiency of such therapy with help the genomic editor of information agency "ITAR-TASS", on October 27. The Israeli geneticists created therapy on the basis of the "Nobel" genomic CRISPR/Cas9 editor which allows to correct mutations in a gene RAG2 connected with development of a heavy combined immunodeficiency, or a timichesky alimfoplaziya. The press service reported University named after Meira Bar Ilan. Work is published on Friday in Nauchny zhurnal Nature by Communications. "We...